Isomorphic Labs, a Google-backed AI company, is set to begin human trials for cancer drugs designed by AI, raising both hope ...

In this episode presented by IQVIA, BioSpace's head of insights Lori Ellis discusses the evolving role of local qualified ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Onda on Wednesday launched a free ap for surfers that personalizes local weather forecasts and community updates, starting ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

Historian Niall Ferguson warns against unlimited access to AI tools for those under 25, calling it a disaster for brain development.

One of the biggest barriers to the adoption of any new biotechnology tool is validation and regulatory clarity.

Wayve was among the first unicorn AI startups in the UK, getting funding of over $1 billion for its self-driving artificial ...

As AI becomes central, the ability to ask the right question isn’t just a technical skill but a foundational one.

Grok 4 is xAI’s most advanced model yet, but early praise is clashing with old scandals and fresh tests of its limits.

By harnessing cloud-native elasticity and global reach, the BullFrog Data Networks Solutions Library enables lightning-fast deployment of the bfLEAP™ platform. Clients working with BullFrog AI can now ...

More physicians than ever are turning to AI to improve efficiency — from administrative tasks to diagnosis and treatment — ...